Your browser doesn't support javascript.
loading
Persistent viral RNA positivity during the recovery period of a patient with SARS-CoV-2 infection.
Yang, Jian-Rong; Deng, Dao-Ting; Wu, Nan; Yang, Bin; Li, Hong-Juan; Pan, Xiao-Ben.
Afiliação
  • Yang JR; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Deng DT; Department of Clinical Laboratory, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Wu N; Hepatology Institute, Peking University People's Hospital, Beijing, China.
  • Yang B; Department of Anesthesiology, Chongqing University Cancer Hospital, Chongqing, China.
  • Li HJ; Department of Hepatology Center, Key Laboratory of Aging and Cancer Biology of Zhejiang Province, College of Basic Medicine, The Affiliated Hospital of Hangzhou Normal University, School of Medicine, Hangzhou Normal University, Hangzhou, China.
  • Pan XB; Department of Hepatology Center, Key Laboratory of Aging and Cancer Biology of Zhejiang Province, College of Basic Medicine, The Affiliated Hospital of Hangzhou Normal University, School of Medicine, Hangzhou Normal University, Hangzhou, China.
J Med Virol ; 92(9): 1681-1683, 2020 09.
Article em En | MEDLINE | ID: mdl-32330293
As an emerging infectious disease, the clinical course and virological course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remain to be further investigated. In this case report, we described a case of SARS-CoV-2 infection with the clinical course for more than 2 months. This patient had recovered from pneumonia after treatment. The viral RNA of throat swabs became negative and the viral-specific antibodies were produced during the recovery period. However, the viral RNA reappeared and additionally persisted in throat swabs for more than 40 days. In addition, the viral RNA was detected in multiple types of specimens with extremely high titers in the saliva. In conclusion, these findings indicate that SARS-CoV-2 can cause a long clinical course. The coexistence of viral RNA and viral-specific antibodies may imply an immune evasion of SARS-CoV-2 from the host's immune system.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Eliminação de Partículas Virais / SARS-CoV-2 / COVID-19 Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Eliminação de Partículas Virais / SARS-CoV-2 / COVID-19 Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article